Cargando…
Cancer-Associated Fibroblast: Role in Prostate Cancer Progression to Metastatic Disease and Therapeutic Resistance
Prostate cancer (PCa) is one of the most common cancers in European males. Although therapeutic approaches have changed in recent years, and several new drugs have been approved by the Food and Drug Administration (FDA), androgen deprivation therapy (ADT) remains the standard of care. Currently, PCa...
Autores principales: | Bedeschi, Martina, Marino, Noemi, Cavassi, Elena, Piccinini, Filippo, Tesei, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000679/ https://www.ncbi.nlm.nih.gov/pubmed/36899938 http://dx.doi.org/10.3390/cells12050802 |
Ejemplares similares
-
Cancer associated fibroblasts confer shear resistance to circulating tumor cells during prostate cancer metastatic progression
por: Ortiz-Otero, Nerymar, et al.
Publicado: (2020) -
Repurposing the Antiplatelet Agent Ticlopidine to Counteract the Acute Phase of ER Stress Condition: An Opportunity for Fighting Coronavirus Infections and Cancer
por: Tesei, Anna, et al.
Publicado: (2022) -
Predictors for progression of metastatic prostate cancer to castration-resistant prostate cancer in Indians
por: Sureka, Sanjoy Kumar, et al.
Publicado: (2016) -
Progression of metastatic castrate-resistant prostate cancer: impact of therapeutic intervention in the post-docetaxel space
por: Sartor, A Oliver
Publicado: (2011) -
Risk factors for progression to castration-resistant prostate cancer in metastatic prostate cancer patients
por: Lin, Ting-Ting, et al.
Publicado: (2019)